Yifan Tu
Fudan University
12 Papers
Yifan Tu is an academic researcher from Fudan University. The author has contributed to research in topics: Drug delivery & Glioma. The author has an hindex of 9, co-authored 9 publications.
Chat about Author
Papers
F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery
Quanyin Hu,Guangzhi Gu,Zhongyang Liu,Mengyin Jiang,Ting Kang,Deyu Miao,Yifan Tu,Zhiqing Pang,Qingxiang Song,Lei Yao,Huimin Xia,Hongzhan Chen,Xinguo Jiang,Xiaoling Gao,Jun Chen +14 more
TL;DR: The findings here clearly indicated that the strategy by co-administrating a tumor homing and penetrating peptide with functionalized nanoparticles dual-targeting both glioma cells and neovasculature could significantly improve the anti-glioma drug delivery.
194
Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration
Zhongyang Liu,Mengyin Jiang,Ting Kang,Deyu Miao,Guangzhi Gu,Qingxiang Song,Lei Yao,Quanyin Hu,Yifan Tu,Zhiqing Pang,Hong-Zhuan Chen,Xinguo Jiang,Xiaoling Gao,Jun Chen +13 more
TL;DR: Lf-NP may serve as a promising nose-to-brain drug delivery carrier especially for peptides and proteins especially for neuroprotection peptides.
184
PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
Guangzhi Gu,Huimin Xia,Quanyin Hu,Zhongyang Liu,Mengyin Jiang,Ting Kang,Deyu Miao,Yifan Tu,Zhiqing Pang,Qingxiang Song,Lei Yao,Hongzhan Chen,Xiaoling Gao,Jun Chen +13 more
TL;DR: The findings here offered strong evidence for the glioblastoma-targeting therapy of ALMWP-NP-PTX, and could also lead to a significant advancement in the application of CPPs for targeted therapy of glioma.
170
B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide.
Zhongyang Liu,Xiaoling Gao,Ting Kang,Mengyin Jiang,Deyu Miao,Guangzhi Gu,Quanyin Hu,Qingxiang Song,Lei Yao,Yifan Tu,Hong-Zhuan Chen,Xinguo Jiang,Jun Chen +12 more
TL;DR: It is suggested that B6-NP might serve as a promising DDS for facilitating the brain delivery of neuropeptides in the treatment of Alzheimer's disease.
144
CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels.
Quanyin Hu,Xiaoling Gao,Ting Kang,Xingye Feng,Di Jiang,Yifan Tu,Qingxiang Song,Lei Yao,Xinguo Jiang,Hong-Zhuan Chen,Jun Chen +10 more
TL;DR: The findings here indicated that CGKRK peptide-functionalized nanoparticulate DDS could be used as an effective tumor angiogenic blood vessels and tumor cells dual-targeting DDS and might provide a great promising approach for reducing the disadvantages of antiangiogenic therapy alone.
79